Singular Genomics Systems Inc (OMIC)
21.65
-0.25
(-1.14%)
USD |
NASDAQ |
Nov 22, 16:00
21.65
0.00 (0.00%)
After-Hours: 16:00
Singular Genomics Systems Total Assets (Quarterly): 186.55M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 186.55M |
| June 30, 2024 | 220.00M |
| March 31, 2024 | 239.10M |
| December 31, 2023 | 265.47M |
| September 30, 2023 | 284.52M |
| June 30, 2023 | 283.98M |
| March 31, 2023 | 305.47M |
| December 31, 2022 | 327.98M |
| Date | Value |
|---|---|
| September 30, 2022 | 345.48M |
| June 30, 2022 | 366.41M |
| March 31, 2022 | 342.11M |
| December 31, 2021 | 355.65M |
| September 30, 2021 | 370.83M |
| June 30, 2021 | 383.98M |
| March 31, 2021 | 155.62M |
| December 31, 2020 | 30.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
30.50M
Minimum
Dec 2020
383.98M
Maximum
Jun 2021
278.98M
Average
294.99M
Median
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 6.113B |
| Azenta Inc | 2.100B |
| Harvard Bioscience Inc | 131.24M |
| Bionano Genomics Inc | 87.36M |
| Akoya Biosciences Inc | 129.97M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 63.30M |
| Shareholders Equity (Quarterly) | 123.25M |
| Debt to Equity Ratio | 0.0419 |
| Current Ratio | 7.372 |
| Net Debt Paydown Yield | 2.53% |